In a filing, BioXcel Therapeutics Inc revealed its Chief Commercial Officer Wiley Matthew T. unloaded Company’s shares for reported $3450.0
BioXcel Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Wiley Matthew T. unloaded Company’s shares for reported $3450.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BioXcel Therapeutics
BioXcel Therapeutics Inc’s recently made public that its Chief Commercial Officer Wiley Matthew T. unloaded Company’s shares for reported $3450.0
BioXcel Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Wiley Matthew T. unloaded Company’s shares for reported $3450.0
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) observed a substantial increase in its stock value, rising by 26.02% in the prior trading
